Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia

A report from the italian AIEOP study group

Silvia Bresolin, Paola De Filippi, Francesca Vendemini, Mirko D'Alia, Marco Zecca, Lueder H. Meyer, Cesare Danesino, Franco Locatelli, Riccardo Masetti, Giuseppe Basso, Geertruy te Kronnie

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Juvenile myelomonocytic leukemia (JMML) is a rare aggressive disease of early childhood. Driver mutations in the Ras signaling pathways are a key feature of JMML patients. Mutations in SETBP1 and JAK3 were recently identified in a subset of JMML patients characterized by poor prognosis and progression of disease. In this study, we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with JMML, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1.JMML xenotransplantation and colony assay provide an initial understanding of the secondary nature of these events occurring in early precursor cells and suggest a different propagating capacity of clones harboring particular mutations.

Original languageEnglish
Pages (from-to)28914-28919
Number of pages6
JournalOncotarget
Volume7
Issue number20
DOIs
Publication statusPublished - May 17 2016

Fingerprint

Juvenile Myelomonocytic Leukemia
Mutation
Heterologous Transplantation
Rare Diseases
Disease Progression
Clone Cells

Keywords

  • JAK3
  • JMML
  • Murine model
  • SETBP1

ASJC Scopus subject areas

  • Oncology

Cite this

Bresolin, S., De Filippi, P., Vendemini, F., D'Alia, M., Zecca, M., Meyer, L. H., ... te Kronnie, G. (2016). Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group. Oncotarget, 7(20), 28914-28919. https://doi.org/10.18632/oncotarget.8016

Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia : A report from the italian AIEOP study group. / Bresolin, Silvia; De Filippi, Paola; Vendemini, Francesca; D'Alia, Mirko; Zecca, Marco; Meyer, Lueder H.; Danesino, Cesare; Locatelli, Franco; Masetti, Riccardo; Basso, Giuseppe; te Kronnie, Geertruy.

In: Oncotarget, Vol. 7, No. 20, 17.05.2016, p. 28914-28919.

Research output: Contribution to journalArticle

Bresolin, S, De Filippi, P, Vendemini, F, D'Alia, M, Zecca, M, Meyer, LH, Danesino, C, Locatelli, F, Masetti, R, Basso, G & te Kronnie, G 2016, 'Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group', Oncotarget, vol. 7, no. 20, pp. 28914-28919. https://doi.org/10.18632/oncotarget.8016
Bresolin, Silvia ; De Filippi, Paola ; Vendemini, Francesca ; D'Alia, Mirko ; Zecca, Marco ; Meyer, Lueder H. ; Danesino, Cesare ; Locatelli, Franco ; Masetti, Riccardo ; Basso, Giuseppe ; te Kronnie, Geertruy. / Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia : A report from the italian AIEOP study group. In: Oncotarget. 2016 ; Vol. 7, No. 20. pp. 28914-28919.
@article{a1d05bf9443a49c9921df41c7bdbd4dd,
title = "Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group",
abstract = "Juvenile myelomonocytic leukemia (JMML) is a rare aggressive disease of early childhood. Driver mutations in the Ras signaling pathways are a key feature of JMML patients. Mutations in SETBP1 and JAK3 were recently identified in a subset of JMML patients characterized by poor prognosis and progression of disease. In this study, we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with JMML, identifying 11.4{\%} of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1.JMML xenotransplantation and colony assay provide an initial understanding of the secondary nature of these events occurring in early precursor cells and suggest a different propagating capacity of clones harboring particular mutations.",
keywords = "JAK3, JMML, Murine model, SETBP1",
author = "Silvia Bresolin and {De Filippi}, Paola and Francesca Vendemini and Mirko D'Alia and Marco Zecca and Meyer, {Lueder H.} and Cesare Danesino and Franco Locatelli and Riccardo Masetti and Giuseppe Basso and {te Kronnie}, Geertruy",
year = "2016",
month = "5",
day = "17",
doi = "10.18632/oncotarget.8016",
language = "English",
volume = "7",
pages = "28914--28919",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "20",

}

TY - JOUR

T1 - Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia

T2 - A report from the italian AIEOP study group

AU - Bresolin, Silvia

AU - De Filippi, Paola

AU - Vendemini, Francesca

AU - D'Alia, Mirko

AU - Zecca, Marco

AU - Meyer, Lueder H.

AU - Danesino, Cesare

AU - Locatelli, Franco

AU - Masetti, Riccardo

AU - Basso, Giuseppe

AU - te Kronnie, Geertruy

PY - 2016/5/17

Y1 - 2016/5/17

N2 - Juvenile myelomonocytic leukemia (JMML) is a rare aggressive disease of early childhood. Driver mutations in the Ras signaling pathways are a key feature of JMML patients. Mutations in SETBP1 and JAK3 were recently identified in a subset of JMML patients characterized by poor prognosis and progression of disease. In this study, we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with JMML, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1.JMML xenotransplantation and colony assay provide an initial understanding of the secondary nature of these events occurring in early precursor cells and suggest a different propagating capacity of clones harboring particular mutations.

AB - Juvenile myelomonocytic leukemia (JMML) is a rare aggressive disease of early childhood. Driver mutations in the Ras signaling pathways are a key feature of JMML patients. Mutations in SETBP1 and JAK3 were recently identified in a subset of JMML patients characterized by poor prognosis and progression of disease. In this study, we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with JMML, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1.JMML xenotransplantation and colony assay provide an initial understanding of the secondary nature of these events occurring in early precursor cells and suggest a different propagating capacity of clones harboring particular mutations.

KW - JAK3

KW - JMML

KW - Murine model

KW - SETBP1

UR - http://www.scopus.com/inward/record.url?scp=84969760884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969760884&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.8016

DO - 10.18632/oncotarget.8016

M3 - Article

VL - 7

SP - 28914

EP - 28919

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 20

ER -